Crinetics’ $500M offering; Boehringer inks deal with macrocycles biotech

Plus, news about Inhibikase, Bio-Thera, Richter, InnoCare and Scholar Rock:

Crinetics prices $500M offering: The San Diego biotech upsized the offering …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

Hospital-based donor care linked to longer lung transplant survival rates

A new study by Penn researchers examined, for the first time, the differences in lung transplant graft outcomes from organs recovered from the two types

June 26, 2024

Risk Adjusted Net Present Value: What is the current valuation of Pfizer’s Atirmociclib

The revenue for Atirmociclib is expected to reach an annual total of $388 mn by 2040 globally based off GlobalData’s Revenue Model. The drug’s revenue

July 2, 2024

Large-Core Strokes Do Better Long-Term With Thrombectomy

PHOENIX — Endovascular thrombectomy for large-core acute ischemic stroke improved long-term outcomes, the SELECT2 trial affirmed. The intervention shifted the 1-year modified Rankin Scale (mRS)

February 14, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.